MINDAX LIMITED — Proxy Solicitation & Information Statement 2025

Jun 2, 2025

==> picture [594 x 132] intentionally omitted <==

3 June 2025

MINDAX LIMITED – EXTRAORDINARY GENERAL MEETING

Dear Shareholder

I am pleased to invite you to attend the extraordinary general meeting of Mindax Limited ( Mindax or the Company ), which will be held at 2:00 pm (AWST) on Thursday, 3 July 2025 ( Meeting ) at Level 13, 26 St Georges Terrace, Perth WA 6000.

In accordance with the Corporations Act 2001 (Cth), the Notice of Meeting and the accompanying Explanatory Statement are being made available to shareholders electronically. The Mindax Notice of Meeting is available for you to view and download on the Company’s website at http://mindax.com.au/investor-relations/asx-announcements or from the ASX announcements website (www.asx.com.au) using the ASX code: MDX.

Shareholders will be able to participate in person at the Meeting.

Your participation in the Meeting is important to us. If you are unable to attend the Meeting at the scheduled time, you can participate in the Meeting by lodging a proxy vote. As voting on all resolutions at the Meeting will be conducted by poll, your lodged proxy vote will be included in the vote on each resolution.

Shareholders can either lodge the proxy appointment online at https://investor.automic.com.au/#/loginsah or sign and return the proxy form to the Company’s share registry, Automic, in accordance with the instructions on the form, so that it is received by 2:00 pm (AWST) on 1 July 2025 .

Mindax is committed to promoting positive environmental outcomes, so we encourage all shareholders to provide an email address to receive their communications electronically. This ensures we are providing you with the information you need in the fastest, most cost-effective manner possible, while also significantly reducing our environmental impact.

You can make an election as to whether you would like to receive certain documents, including annual reports and documents related to shareholder meetings (for example, notices of meeting and proxy/voting forms), as follows:

1. You can make a standing election to receive the documents in physical or electronic form;

2. You can make a one-off request to receive a document in physical or electronic form; or

3. You can elect not to receive certain documents such as annual reports.

To update your details online, visit https://investor.automic.com.au/#/home. Follow the prompts to update your information, add your email address and update your ‘Communications’ preferences.

If you are unable to access the meeting materials online, please call the Company Secretary on +61 8 9389 2111.

For and on behalf of the Board,

Dennis Wilkins Company Secretary

MINDAX LIMITED

www.mindax.com.au

MINDAX LIMITED ACN 106 866 442

NOTICE OF EXTRAORDINARY GENERAL MEETING

AND

EXPLANATORY STATEMENT

AND

PROXY FORM

Date of Meeting 3 July 2025 Time of Meeting 2:00 pm (AWST)

Place of Meeting Level 13, 26 St Georges Terrace, Perth WA 6000

This Notice of Extraordinary General Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their accountant, solicitor or other professional adviser prior to voting. www.mindax.com.au

MINDAX LIMITED ACN 106 866 442

NOTICE OF EXTRAORDINARY GENERAL MEETING

The Board of Directors of Mindax Limited (the Company ) advises that an Extraordinary General Meeting of the Shareholders the C ompany will be held at Level 13, 26 St Georges Terrace, Perth WA 6000 on 3 July 2025 at 2:00 pm (AWST) ( Meeting ) for the purpose of consideration of the resolutions as set out in this Notice and the accompanying Explanatory Materials.

Shareholders are welcome to participate in person at the Meeting.

Capitalised terms and abbreviations used in this Notice and Explanatory Statement are defined in the Glossary.

Your vote is important

The business of the Meeting affects your Shareholding, and your vote is important. Voting on each item of business will be conducted by poll. The Board encourages all Shareholders to either vote at the Meeting or lodge a Proxy Form prior to the deadline (being no later than 2:00 pm (AWST) on 1 July 2025). Information on how to lodge a proxy is set out on the Proxy Form.

Voting eligibility

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth), that the persons eligible to vote at the Meeting are those who are registered Shareholders at 2:00 pm (AWST) on 1 July 2025.

Voting during the Meeting

If you hold Shares in the Company, you will be able to vote on the Resolutions during the Meeting (subject to any voting exclusions and voting prohibitions as set out in the Notice). Voting on each item of business will be by poll. However, the Directors strongly encourage Shareholders to lodge their Proxy Form in accordance with the instructions below to assist in the orderly conduct of the Meeting.

Voting by proxy

All Shareholders are invited and encouraged to attend the Meeting and vote in person or, if they are unable to attend in person, sign and return the Proxy Form to the Company in accordance with the instructions on the form. Lodgement of a Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in person. Only an individual may be appointed a proxy.

To vote by proxy, please complete and sign the enclosed personalised Proxy Form and return by no later than 2:00 pm (AWST) 1 July 2025:

• by lodging your Proxy Form online at https://investor.automic.com.au/#/loginsah; or

• by delivering your completed Proxy Form by email to meetings@automicgroup.com.au; or

• by posting your completed Proxy Form to Automic, GPO Box 5193, Sydney NSW 2001; or

• by delivering your completed Proxy Form by fax to Automic at +61 2 8583 3040; or

• by delivering your Completed Proxy Form by hand to Automic at Level 5, 126 Philip Street, Sydney NSW 2000.

In accordance with section 249L of the Corporations Act, Shareholders are advised that:

• each Shareholder entitled to attend and vote at the Meeting has a right to appoint a proxy;

• the proxy need not be a Shareholder of the Company and can be an individual or a body corporate; and

• a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the member appoints two proxies and the appointment does not specify the proportion or number of the member’s votes, each proxy may exercise one-half of the votes.

Chair as proxy

If you appoint the Chair of the Meeting as your proxy (or the Chair becomes your proxy by default) and you do not direct your proxy how to vote on the proposed Resolutions set out in this Notice, then you will be authorising the Chair to vote as the Chair decides on the proposed Resolutions (even if the Resolution is connected with the remuneration of a member

2

Extraordinary General Meeting – 3 July 2025

MINDAX LIMITED

of the Company's KMP). Where permitted, the Chair intends to vote (where appropriately authorised) as proxy in favour of each Resolution.

If you appoint the Chair as your proxy and wish to direct the Chair how to vote, you can do so by marking the boxes for the relevant Resolution (i.e., by directing to vote "For", "Against" or "Abstain").

If you appoint a member of the KMP (other than the Chair) or any Closely Related Party of a member of the KMP as your proxy, you must direct that person how to vote on Resolutions 5, 6, and 7 if you want your Shares to be voted on those Resolutions. If you appoint a member of the KMP (other than the Chair) or any Closely Related Party of a member of the KMP and you do not direct them how to vote on Resolutions 5, 6 and 7 such a person will not cast your votes on those Resolutions and your votes will not be counted in calculating the required majority on the poll for that Resolution.

Corporate representatives

A body corporate who is a Shareholder or proxy must appoint an individual as its corporate representative if it wishes to attend and vote at the Meeting. If you are a corporate representative, you will need to provide evidence of your appointment as a corporate representative with the share registry prior to the Meeting or have previously provided the Company with evidence of your appointment.

Powers of attorney

If you appoint an attorney to attend and vote at the Meeting on your behalf, the power of attorney (or a certified copy) must be received by the share registry by 2:00 pm (AWST) on 1 July 2025, unless the power of attorney has previously been lodged with the share registry.

Shareholder questions

Shareholders will be able to ask questions relevant to the business of the Meeting at the Meeting.

Shareholders who are unable to attend the Meeting or wish to submit questions prior to the Meeting may submit written questions by emailing the Company Secretary on info@mindax.com.au. In order for questions to be appropriately considered, it is recommended that questions are received by 5:00 pm (AWST), 26 June 2025.

The more frequently raised Shareholder issues will be addressed by the Chair during the course of the Meeting. While there will be an allotted time for questions, the Board will endeavour to respond to as many Shareholder questions as possible. However, there may still not be sufficient time available at the Meeting to address all of the questions raised. Please note that individual responses will not be sent to Shareholders.

Electronic communication

All Shareholders may, and are encouraged to, elect to receive communications from the Company’s share registry electronically. The Company strives to avoid, to the fullest extent permitted by law, sending information to shareholders via physical means. To provide or update your email address, please contact the Company’s share registry.

3

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

AGENDA

RESOLUTION 1: RATIFICATION OF PRIOR ISSUE OF SHARES

To consider and, if thought fit, to pass the following as an ordinary resolution :

“That, for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify and approve the issue of 9,001,782 Shares to non-related parties issued within the Company’s issuance capacity under Listing Rule 7.1, for the purposes and on the terms and conditions set out in the Explanatory Statement.”

Voting Exclusion Statement: The Company will disregard any votes cast on Resolution 1 by:

• Ms Huichan Lai (or her nominee);

• or an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of Resolution 1 by:

• (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

• (b) the Chair as proxy for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

• (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and

• (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 2: RATIFICATION OF PRIOR ISSUE OF SHARES

To consider and, if thought fit, to pass the following as an ordinary resolution :

“That, for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify and approve the issue of 96,875,000 Shares to non-related parties issued within the Company’s issuance capacity under Listing Rule 7.1, for the purposes and on the terms and conditions set out in the Explanatory Statement.”

Voting Exclusion Statement: The Company will disregard any votes cast on Resolution 2 by:

• Ms Huichan Lai (or her nominee);

• or an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of Resolution 2 by:

• (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

• (b) the Chair as proxy for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

• (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and

• (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 3: RATIFICATION OF PRIOR ISSUE OF SHARES

To consider and, if thought fit, to pass the following as an ordinary resolution :

"“That, for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify and approve the issue of 109,090,908 Shares to non-related parties issued within the Company’s issuance capacity under Listing Rule 7.1, for the purposes and on the terms and conditions set out in the Explanatory Statement.”

Voting Exclusion Statement: The Company will disregard any votes cast on Resolution 3 by or on behalf of:

• Ms Huichan Lai and Mr Zelong Zeng (or their nominees);

• or an Associate of that person or those persons.

4

MINDAX LIMITED

Extraordinary General Meeting – 3 July 2025

However, this does not apply to a vote cast in favour of Resolution 3 by:

• (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

• (b) the Chair as proxy for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

• (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and

• (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 4: RATIFICATION OF PRIOR ISSUE OF SHARES

To consider and, if thought fit, pass the following as an ordinary resolution :

“That, for the purpose of section Listing Rule 7.4 and for all other purposes, Shareholders ratify and approve the issue of 22,237,077 Shares to non-related parties issued within the Company’s issuance capacity under Listing Rule 7.1, for the purposes and on the terms and conditions set out in the Explanatory Statement.”

Voting Exclusion Statement: The Company will disregard any votes cast on Resolution 4 by or on behalf of:

• Mr Jianchun Yang (or his nominee);

• or an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of Resolution 4 by:

• (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

• (b) the Chair as proxy for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

• (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and

• (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 5: APPROVAL OF GRANT OF OPTIONS TO MR BENJAMIN CHOW

To consider and, if thought fit, pass the following as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11, sections 195(4) and 208 of the Corporations Act and for all other purposes, the issue to Mr Benjamin Chow, or his nominees, for nil consideration, of 16,000,000 Director Options to acquire fully paid ordinary Shares in the capital of the Company, at an exercise price of $0.07, expiring on 30 November 2025 and on the terms and conditions outlined in the Explanatory Statement and in Annexure A, is hereby approved.”

Voting Prohibition Statement: A vote on Resolution 5 must not be cast (in any capacity) by or on behalf of a related party of the Company to whom the Resolution would permit a financial benefit to be given, or an Associate of such a related party ( Excluded Party ). However, this prohibition does not apply if the vote is cast by a person as proxy appointed by writing that specifies how the proxy is to vote on the Resolution, and it is not cast on behalf of an Excluded Party.

Further, a person appointed as a proxy must not vote, on the basis of that appointment, on Resolution 5 if:

• (a) the proxy is either:

• (i) a member of the KMP; or

• (ii) a Closely Related Party of such a member; and

• (b) the appointment does not specify the way the proxy is to vote on this Resolution.

Provided the Chair is not an Excluded Party, the above prohibition does not apply if:

• (a) the proxy is the Chair; and

• (b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with remuneration of a member of the KMP.

5

Extraordinary General Meeting – 3 July 2025

MINDAX LIMITED

Voting Exclusion Statement: The Company will disregard any vote cast in favour of the Resolution by or on behalf of Mr Chow (or his nominees) and any other person who will obtain a material benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

• (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

• (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

• (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and

• (ii) the holder votes on the Resolution in accordance with the directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 6: APPROVAL OF GRANT OF OPTIONS TO MR QINGLONG ZENG

To consider and, if thought fit, pass the following as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11, sections 195(4) and 208 of the Corporations Act and for all other purposes, the issue to Mr Qinglong Zeng, or his nominees, for nil consideration, of 8,000,000 Director Options to acquire fully paid ordinary Shares in the capital of the Company, at an exercise price of $0.07, expiring on 30 November 2025 and on the terms and conditions outlined in the Explanatory Statement and in Annexure A, is hereby approved.

Voting Prohibition Statement: A vote on Resolution 6 must not be cast (in any capacity) by or on behalf of an Excluded Party. However, this prohibition does not apply if the vote is cast by a person as proxy appointed by writing that specifies how the proxy is to vote on the Resolution, and it is not cast on behalf of an Excluded Party.

Further, a person appointed as a proxy must not vote, on the basis of that appointment, on Resolution 6 if:

• (a) the proxy is either:

• (i) a member of the KMP; or

• (ii) a Closely Related Party of such a member; and

• (b) the appointment does not specify the way the proxy is to vote on this Resolution.

Provided the Chair is not an Excluded Party, the above prohibition does not apply if:

• (a) the proxy is the Chair; and

• (b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with remuneration of a member of the KMP.

Voting Exclusion Statement: The Company will disregard any vote cast in favour of the Resolution by or on behalf of Mr Zeng (or his nominees) and any other person who will obtain a material benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

• (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

• (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

• (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and

• (ii) the holder votes on the Resolution in accordance with the directions given by the beneficiary to the holder to vote in that way.

6

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

RESOLUTION 7: APPROVAL OF GRANT OF OPTIONS TO MR BIAOZHUN ZHU

To consider and, if thought fit, pass the following as an ordinary resolution :

“That, for the purposes of Listing Rule 10.11, sections 195(4) and 208 of the Corporations Act and for all other purposes, the issue to Mr Biaozhun Zhu, or his nominees, for nil consideration, of 8,000,000 Director Options to acquire fully paid ordinary Shares in the capital of the Company, at an exercise price of $0.07, expiring on 30 November 2025 and on the terms and conditions outlined in the Explanatory Statement and in Annexure A, is hereby approved.

Voting Prohibition Statement: A vote on Resolution 7 must not be cast (in any capacity) by or on behalf of an Excluded Party. However, this prohibition does not apply if the vote is cast by a person as proxy appointed by writing that specifies how the proxy is to vote on the Resolution, and it is not cast on behalf of an Excluded Party.

Further, a person appointed as a proxy must not vote, on the basis of that appointment, on Resolution 7 if:

• (a) the proxy is either:

• (i) a member of the KMP; or

• (ii) a Closely Related Party of such a member; and

• (b) the appointment does not specify the way the proxy is to vote on this Resolution.

Provided the Chair is not an Excluded Party, the above prohibition does not apply if:

• (a) the proxy is the Chair; and

• (b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with remuneration of a member of the KMP.

Voting Exclusion Statement: The Company will disregard any vote cast in favour of the Resolution by or on behalf of Mr Zhu (or his nominees) and any other person who will obtain a material benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of the Resolution by:

• (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or

• (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

• (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and

• (ii) the holder votes on the Resolution in accordance with the directions given by the beneficiary to the holder to vote in that way.

By order of the Board:

......................................... Dennis Wilkins Company Secretary 23 May 2025

7

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

MINDAX LIMITED ACN 106 866 442

EXPLANATORY STATEMENT

This Explanatory Statement has been prepared for the Shareholders of the Company in connection with the business to be conducted at the EGM of the Company to be held at Level 13, 26 St Georges Terrace, Perth, WA 6000, on 3 July 2025 commencing at 2:00 pm (AWST) and any adjournment thereof.

This Explanatory Statement is intended to provide Shareholders with sufficient information to assess the merits of the matters set forth in the Notice for approval at the Meeting. The Directors recommend that Shareholders read this Explanatory Statement in full before making any decision in relation to the Resolutions.

Terms used in this Explanatory Statement will, unless the context otherwise requires, have the same meaning given to them in the Glossary as contained in this Explanatory Statement.

1. RESOLUTION 1 TO 4: RATIFICATION OF PRIOR ISSUE OF SHARES

1.1 General

The Company issued the following Shares in accordance with Listing Rule 7.1:

Issue Date	Issue Price	Number of Shares	Total Amount Raised
6 March 2025	$0.034	2,941,176	$100,000
	$0.033	6,060,606	$200,000
	Resolution 1 Total	9,001,782	$300,000
12 March 2025	$0.032 Resolution 2 Total	96,875,000 96,875,000	$3,100,000 $3,100,000
18 March 2025	$0.033	109,090,908	$3,600,000
	Resolution 3 Total	109,090,908	$3,600,000
27 March 2025	$0.033 $0.034 Resolution 4 Total	6,060,606 16,176,471 22,237,077	$200,000 $550,000 $750.000

Details regarding the placement are set out in the Company’s ASX announcement dated 25 March 2025, titled “Share Placement and Investment .”

Funds raised pursuant to the placements will be used to accelerate development pathways for the Company's flagship Mt Forrest Iron Project (operated as a joint venture between Mindax, Yilgiron Pty Ltd and Norton Gold Fields (Pty) Ltd with proceeds being applied as follows:

• Project and corporate costs associated with the project;

• Assessing and concluding other project opportunities in line with the Company’s stated objectives including an investment in Doublebell Resource Wealth Pty Ltd ( Doublebell ); and

• Exploring opportunities to consolidate the Mid-West Iron region, including an investment in Cashmere Iron Limited ( Cashmere ), which the Company considers a significant move toward achieving the critical mass needed to support the Mid-West Shared Infrastructure Project (MWSIP).

8

Extraordinary General Meeting – 3 July 2025

MINDAX LIMITED

	Activity		Cost AUD
	 Investment in Doublebell		 $3,100,000
	 Investment in Cashmere		 $3,000,000
	 Project and corporate costs		 $1,200,000
	 General Working Capital		 $450,000
	 Total		 $7,750,000

Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12-month period to 15% of the fully paid ordinary shares it had on issue at the start of that period.

The issues of the Shares do not fit within any of these exceptions and, as they have not yet been approved by Shareholders, they effectively use up part of the 15% limit in Listing Rule 7.1, reducing the Company’s capacity to issue further Equity Securities without Shareholder approval under Listing Rules 7.1 for the 12-month periods following the respective Shares issue dates.

Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of Equity Securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the company’s capacity to issue further Equity Securities without shareholder approval under that rule.

The Company wishes to retain as much flexibility as possible to issue additional Equity Securities into the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1.

To this end, Resolutions 1 to 4 seek Shareholder approval to the issue of the Shares under and for the purposes of Listing Rule 7.4.

If Resolutions 1 to 4 are passed, the Shares will be excluded in calculating the Company’s 15% limit in Listing Rule 7.1, effectively increasing the number of Equity Securities it can issue without Shareholder approval over the 12-month periods following the respective Share issue dates.

If Resolutions 1 to 4 are not passed, the Shares will be included in calculating the Company’s 15% limit in Listing Rule 7.1, effectively decreasing the number of Equity Securities it can issue without Shareholder approval over the 12-month periods following the respective Share issue dates.

Resolutions 1 to 4 are ordinary resolutions, each requiring to be passed by a simple majority of votes cast by the Shareholders entitled to vote on the Resolution.

1.2 Information required by Listing Rule 7.5

In accordance with the requirements of Listing Rule 7.5, the following information is provided for Resolution 1.

• (a) The Shares were allotted and issued to Ms Huichan Lai who is not a related party of the Company:

• (b) 9,001,782 Shares were allotted and issued by the Company pursuant to Listing Rule 7.1, being fully paid ordinary shares which rank equally with all other Shares on issue.

• (c) The Company issued 9,001,782 Shares on 6 March 2025.

• (d) The Shares were issued at an issue price of:

• (i) 2,941,176 Shares issued at $0.034 per Share; and

• (ii) 6,060,606 Shares issued at $0.033 per Share;

• (e) The purpose of the issue was to raise funds for the purposes as set out in the Use of Funds table in section 1.1. (f) A voting exclusion statement is included in the Notice.

In accordance with the requirements of Listing Rule 7.5, the following information is provided for Resolution 2.

• (a) The Shares were allotted and issued to Ms Huichan Lai who is not a related party of the Company:

• (b) 96,875,000 Shares were allotted and issued by the Company pursuant to Listing Rule 7.1, being fully paid ordinary shares which rank equally with all other Shares on issue.

9

MINDAX LIMITED

Extraordinary General Meeting – 3 July 2025

• (c) The Company issued 96,875,000 Shares on 12 March 2025.

• (d) The Shares were issued at an issue price of $0.032 per Share.

• (e) The purpose of the issue was to raise funds for the purposes as set out in the Use of Funds table in section 1.1. (f) A voting exclusion statement is included in the Notice.

In accordance with the requirements of Listing Rule 7.5, the following information is provided for Resolution 3.

• (a) The Shares were allotted and issued to the following holders who are not a related party of the Company: (i) Ms Huichan Lai; and

• (ii) Mr Zelong Zeng;

• (b) 109,090,908 Shares were allotted and issued by the Company pursuant to Listing Rule 7.1, being fully paid ordinary shares which rank equally with all other Shares on issue.

• (c) The Company issued 109,090,908 Shares on 18 March 2025.

• (d) The Shares were issued at an issue price of $0.033 per Share.

• (e) The purpose of the issue was to raise funds for the purposes as set out in the Use of Funds table in section 1.1.

• (f) A voting exclusion statement is included in the Notice.

In accordance with the requirements of Listing Rule 7.5, the following information is provided for Resolution 4.

• (a) The Shares were allotted and issued to Mr Jianchun Yang who is not a related party of the Company.

• (b) 22,237,077 Shares were allotted and issued by the Company pursuant to Listing Rule 7.1, being fully paid ordinary shares which rank equally with all other Shares on issue.

• (c) The Company issued 22,237,077 Shares on 27 March 2025.

• (d) The Shares were issued at an issue price of:

• (i) 16,176,471 Shares issued at $0.034 per Share;

• (ii) 6,060,606 Shares issued at $0.033 per Share;

• (e) The purpose of the issue was to raise funds for the purposes as set out in the Use of Funds table in section 1.1.

• (f) A voting exclusion statement is included in the Notice.

1.3 Director’s recommendation

All the Directors consider that Resolutions 1 to 4 are in the best interests of the Company and recommend that Shareholders vote in favour of Resolutions 1 to 4. The Directors have formed this view as the passing of these Resolutions will refresh the Company’s issuing capacity under Listing Rule 7.1 and provide greater flexibility when considering future capital raising opportunities.

2. RESOLUTION 5 TO 7: APPROVAL OF GRANT OF OPTIONS TO DIRECTORS

2.1 General

The Company proposes to grant 16,000,000 Options to Mr Benjamin Chow, 8,000,000 Options to Mr Qinglong Zeng and 8,000,000 Options to Mr Biaozhun Zhu or their nominees, for nil consideration at an exercise price of $0.07, expiring 30 November 2025 ( Director Options ).

The full terms of the Director Options are set out in Annexure A to this Explanatory Statement.

The Directors consider that the grant of Director Options is a cost effective and efficient means for the Company to provide a reward and incentive.

The issue of the 16,000,000 Options to Mr Chow and 8,000,000 Options to each of Mr Zeng and Mr Zhu, subject to shareholder approval, was announced to the ASX on 16 January 2025 and 10 March 2025 “Issue of Options”. At that date the exercise price represented at an approximate 75% premium to the 20-day Volume Weighted Average Price for the Company’s shares at the time they were approved for issue by the Board.

In the event all the Director Options are exercised, Mr Chow (or his nominees) will need to pay a total of $1,120,000, Mr Zeng (or his nominees) will need to pay a total of $560,000 and Mr Zhu (or his nominees) will need to pay a total of $560,000 to the Company.

10

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

2.2 Related party transactions

Chapter 2E of the Corporations Act prohibits a public company from giving a financial benefit to a related party of the public company unless either:

• (a) the giving of the financial benefit falls within one of the nominated exceptions to the provision; or

• (b) prior Shareholder approval is obtained to the giving of the financial benefit and the benefit is given within 15 months after obtaining such approval.

For the purposes of Chapter 2E, directors and their spouses, parents and children of directors and their spouses and persons who were a related party in the previous six months are considered to be related parties of the Company.

Resolutions 5 to 7 provide for the grant of Director Options to related parties which is a financial benefit requiring Shareholder approval. For the purpose of Chapter 2E of the Corporations Act, the following information is provided.

2.3 The related party to whom the proposed Resolutions would permit the financial benefit to be given

Subject to Shareholder approval, the Director Options the subject of Resolutions 7 to 9 will be granted to Messrs Chow, Zeng and Zhu, or their nominees, within one month of the passing of these Resolutions. Messrs Chow, Zeng and Zhu are Directors and are therefore classified as related parties of the Company.

2.4 The nature of, reasons for and basis for the financial benefit

The proposed financial benefit is the grant of 16,000,000 Director Options to Mr Chow, 8,000,000 Director Options to Mr Zeng and 8,000,000 Director Options to Mr Zhu, or their nominees, for no issue price. Each Director Option will allow the holder to subscribe for one ordinary fully paid Share in the Company upon payment of the exercise price. The Director Options each have an exercise price of $0.07 and expire on 30 November 2025.

The Director Options form part of each Director’s incentive for continuing and future efforts. The issue of Director Options to each of Mr Chow, Mr Zeng and Mr Zhu is subject to Resolutions 5, 6 and 7, respectively, being passed. Options are considered to be the appropriate incentive given the Company’s current size and stage of development, being an exploration company endeavouring to preserve cash reserves. If Mr Chow, Mr Zeng and Mr Zhu are to derive any value from the Director Options, the market Share price must be in excess of the exercise price at the time of exercise. As the exercise price of the Director Options is at a 75% premium to the 20-day VWAP at the date of the announcement of the Options and a 4.4% premium to the most recent 20-day VWAP prior to the date of this Notice, the Director Options represent an incentive to Mr Chow, Mr Zeng and Mr Zhu to achieve this increase in the Share price, which would result in an increase in Shareholder value.

The number of Options to be offered to the Directors has been determined based upon a consideration of:

• (a) their total remuneration;

• (b) each Director’s contribution to the progression of the Company’s strategic objectives;

• (c) a review of peer companies’ equity-based remuneration to executive and non-executive directors; and

• (d) the incentives which are generally perceived to be required to attract and retain directors who have appropriate knowledge and expertise for an exploration company with limited cash reserves.

2.5 Directors’ interest and recommendation

In line with best practice identified by ASIC Regulatory Guide 76, none of the Directors make any recommendation in relation to Resolutions 5, 6 and 7 because they may all have a conflict of interest. All of the Directors have therefore declared a material personal interest in Resolutions 5, 6 and 7 at Board meetings and the Board has exercised its right under section 195(4) of the Corporations Act to put the issue to Shareholders to resolve – refer to Section 2.9 of this Explanatory Statement.

2.6 Any other information that is reasonably required to make a decision known to the Company or its officers

• (a) The proposed Resolutions would have the effect of giving authority to the Directors to grant 16,000,000 Director Options to Mr Chow, 8,000,000 Director Options to Mr Zeng and 8,000,000 Director Options to Mr Zhu, or their nominees.

• (b) The exercise of the Director Options is subject to the terms and conditions as set out in Annexure A to this Explanatory Statement and as otherwise included in this Explanatory Statement.

• (c) The fair value of the Director Options proposed to be issued will be determined in accordance with Australian Accounting Standards and is dependent on the date on which the Directors are deemed to have received their offers to participate.

11

MINDAX LIMITED

Extraordinary General Meeting – 3 July 2025

The fair value of Options issued to Directors in previous years is detailed in the Annual Report.

The Directors, in conjunction with the Company's advisers, have provided an indicative value to the Director Options by reference to the Black-Scholes valuation method. The estimated total value of the Director Options to be issued is outlined in Table 3 below.

Table 3: Valuation of Director Options

**Name **	**Relationship **	Number of options	Exercise price	Expiry date	Vesting	Value as determined by Black-Scholes valuation
Benjamin Chow	Director	16,000,000	$0.07	30 November 2025	At date of allotment	$259,200 (i)
Qinglong Zeng	Director	8,000,000	$0.07	30 November 2025	At date of allotment	$129,600 (i)
Biaozhun Zhu	Director	8,000,000	$0.07	30 November 2025	At date of allotment	$129,600(i)

Table 4: Option valuation details

Input	Value
Share price	$0.065
Exercise Price	$0.07
Risk Free Rate	3.69%
Volatility (Annualised)	100%
Start Date	3 July 2025
Expiry Date	30 November 2025
Value per Option	$0.0162 (i)

The Black-Scholes Option Pricing Model is an industry accepted method of valuing equity instruments at the date of grant. However, the Directors do not consider the resultant value as determined by the Black-Scholes Option Pricing Model is in anyway representative of the market value of share options issued. The theoretical fair value of options will be influenced by the terms and conditions upon which the options were granted, the effects of nontransferability, exercise restrictions and behavioural considerations of buyers and sellers of such instruments, the impact of which are ignored in the Black-Scholes Option Pricing Model.

(d) As at the date of this Notice, the issued capital of the Company comprised 2,372,738,547 Shares. If all Director Options granted as proposed above are exercised, and assuming no other Share issues proceed, the effect would be to dilute the Shareholding of existing Shareholders as per Tables 5 below.

Table 5: Dilution

	Existing Shares and Options	Proposed Director Options to Benjamin Chow	Proposed Director Options to Qinglong Zeng	Proposed Director Options to Biaozhun Zhu
Shares and Options	2,372,738,547	2,372,738,547	2,372,738,547	2,372,738,547
Director Options to be granted	32,000,000	16,000,000	8,000,000	8,000,000
New Total	2,404,738,547	2,388,738,547	2,380,738,547	2,380,738,547
Dilutionary effect	1.35%	0.68%	0.34%	0.34%

12

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

(e) Mr Chow, Mr Zeng and Mr Zhu’s current interests in securities of the Company are set out in Table 7 below.

Table 6: Directors’ current interests in securities

**Director **	Shares	Unlisted Options (exercice price $0.07 expiring 30 November 2025)
Benjamin Chow	6,196,000	10,000,000
Qinglong Zeng	25,565,000	6,000,000
Biaozhun Zhu	Nil	2,000,000

(f) The current remuneration for each Director is set out in Table 8 below.

Table 7: Current remuneration of Directors

Director	Annual Director Fees1 (exclusive of superannuation)	Committee Fees (exclusive of superannuation)	Superannuation	Consulting Fees (exclusive of GST)
Benjamin Chow	$180,0002	$5,000	$21,275	$276,0003
Biaozhun Zhu	$45,000	$7,500	$6,038	-
Qinglong Zeng	$95,0003	$7,500	$11,788	-
Total	$320,000	$20,000	$39,101	$372,000

Notes:

1. Exclusive of committee fees.

2. Comprises:

3. (a) Mindax chair fees ($120,000 per annum); and

4. (b) Yilgiron Pty Ltd director fees ($60,000 per annum). Yilgiron Pty Ltd is a subsidiary of Mindax Limited;

5. Comprises:

6. (a) Mindax consultancy fees for executive duties ($11,000 per month, plus GST, paid to BMTC Pty Limited, a company controlled by Mr Chow);

7. (b) Yilgiron Pty Ltd consultancy fees for executive duties ($12,000 per month, plus GST, paid to BMTC Pty Limited, a company controlled by Mr Chow). Mr Chow is also provided with a fully maintained motor vehicle. Yilgiron Pty Ltd is a subsidiary of Mindax Limited.

The remuneration paid to Directors in the financial year ended 3 July 2024 is set out in the Annual Report.

(g) The market price of Shares during the term of the Director Options will normally determine whether or not the Option holder exercises the Options. At the time any Shares are issued pursuant to the exercise of the Director Options, the Company's Shares may be trading at a price which is higher than the exercise price of the Director Options.

The Director Options will not be quoted on ASX and as such have no actual market value. The fully paid ordinary Shares of the Company have been traded on ASX since December 2004. During the twelve months prior to the date of this Notice, the Shares have traded in the range of $0.026 to $0.097. The Director Options are capable of being converted to Shares by payment of the exercise price.

• (h) Under the Australian equivalent of IFRS, the Company is required to expense the value of the Director Options in its profit or loss for the current financial year. Other than as disclosed in this Explanatory Statement, the Directors do not consider that, from an economic and commercial point of view, there are any costs or detriments, including opportunity costs or taxation consequences for the Company or benefits foregone by the Company, in granting the Director Options to Mr Chow, Mr Zeng and Mr Zhu or their nominees pursuant to Resolutions 5, 6 and 7.

• (i) Neither the Directors nor the Company are aware of any other information that would be reasonably required by Shareholders to make a decision in relation to the financial benefits contemplated by Resolutions 5, 6 and 7.

13

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

2.7 Listing Rule 10.11

Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a listed company must not issue or agree to issue equity securities to:

• 10.11.1 a related party;

• 10.11.2 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (30%+) holder in the company;

• 10.11.3 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (10%+) holder in the company and who has nominated a director to the board of the company pursuant to a relevant agreement which gives them a right or expectation to do so;

• 10.11.4 an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3; or

• 10.11.5 a person whose relationship with the company or a person referred to in Listing Rules 10.11.1 to 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be approved by its shareholders,

unless it obtains the approval of its shareholders.

The issue of the Director Options falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in Listing Rule 10.12. It therefore requires the approval of Shareholders under Listing Rule 10.11.

Resolutions 5,6 and 7 seek the required Shareholder approval for the issue of the Director Options to related parties under and for the purposes of Listing Rule 10.11.

If Resolutions 5, 6 and 7 are passed, the Company will be able to proceed with the issue of the Director Options to the Directors within one month after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules). As approval pursuant to Listing Rule 7.1 is not required for the issue of the Director Options (because approval is being obtained under Listing Rule 10.11), the issue of the Director Options will not use up any of the Company’s 15% placement capacity under Listing Rule 7.1.

If Resolutions 5, 6 and 7 are not passed, the Company will not be able to proceed with the issue of the Director Options and the Company will consider alternative incentive strategies, including potentially increasing current cash remuneration to Directors.

2.8 Specific information required by Listing Rule 10.13

The following information is provided in accordance with Listing Rule 10.13.

• (a) The Director Options will be issued to Mr Chow, Mr Zeng and Mr Zhu (or their nominees).

• (b) Mr Chow, Mr Zeng and Mr Zhu fall within the category set out in Listing Rule 10.11.1 by virtue of being Directors of the Company.

• (c) The maximum number of Director Options to be issued to Mr Chow (or his nominees) is 16,000,000. The maximum number of Director Options to be issued to Mr Zeng (or his nominees) is 8,000,000. The maximum number of Director Options to be issued to Mr Zhu (or his nominees) is 8,000,000.

• (d) The Director Options have an exercise price of $0.07, expire on 30 November 2025, and otherwise have the terms and conditions as set out in Annexure A.

• (e) The Director Options will be issued no later than one month after the date of the Meeting (or such longer period of time as ASX may in its discretion allow).

• (f) The Director Options are being issued to Directors for no consideration, so the Company will not receive any funds for the issue.

• (g) The purpose of the issue of the Director Options is to provide an incentive for continuing and future efforts, align the interests of Mr Chow, Mr Zeng and Mr Zhu with those of Shareholders and to provide a cost effective way for the Company to remunerate Mr Chow, Mr Zeng and Mr Zhu which will allow the Company to spend a greater proportion of its cash reserves on its operations than it would if further cash forms of remuneration were given.

• (h) The current remuneration of each Director is shown in Section 2.6(f) of this Explanatory Statement.

• (i) The Director Options are not being issued under an agreement.

• (j) A voting exclusion statement is included in the Notice of Meeting.

14

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

2.9 Section 195 approval

In accordance with section 195 of the Corporations Act, a director of a public company may not vote or be present during meetings of directors when matters in which that director holds a "material personal interest" are being considered.

Since all the Directors are proposed recipients of the Director Options, and each has a conflict of interest in relation to considering the Resolutions relating to the other Directors, the Board is not able to form a quorum at Board meetings necessary to carry out the terms of Resolutions 5, 6, and 7.

The Directors accordingly exercise their right under section 195(4) of the Corporations Act to put the issue to Shareholders to resolve.

15

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

GLOSSARY

In this Explanatory Statement and the Notice, the following terms have the following meanings unless the context otherwise requires:

ASX means ASX Limited ABN 98 008 624 691 and where the context permits, Australian Securities Exchange operated by ASX Limited;

AWST means Australian Western Standard Time (Perth time);

Board means the board of Directors of Mindax, as constituted from time to time;

Chair means the chair of the Meeting;

Closely Related Party has the meaning given in the Corporations Act;

Company or Mindax means Mindax Limited ACN 106 866 442;

Constitution means the constitution of the Company adopted in 2010, as amended;

Corporations Act means the Corporations Act 2001 (Cth), as amended;

Director means a director of the Company;

Director Options has the meaning given in Section 2.1 of the Explanatory Statement;

Equity Securities has the same meaning as in the Listing Rules.

Explanatory Statement means the Explanatory Statement accompanying the Notice;

EGM means an extraordinary general meeting of shareholders;

KMP means the KMP of Mindax from time to time;

Listing Rules means the Listing Rules of the ASX;

Meeting means the 2025 EGM of Shareholders for the purpose of considering the Resolutions;

Notice or Notice of Meeting means the notice of meeting accompanying this Explanatory Statement, including the Proxy Form;

Option means an option to acquire a Share;

Proxy Form means the proxy form attached to the Notice;

Resolution means a resolution contained in the Notice;

Section means a section of the Explanatory Statement;

Share means a fully paid ordinary share in the capital of the Company; and

Shareholder means the holder of a Share.

16

MINDAX LIMITED Extraordinary General Meeting – 3 July 2025

ANNEXURE A

TERMS AND CONDITIONS OF OPTIONS EXPIRING 30 NOVEMBER 2025

The Options are to be issued on the following terms:

1. Each Option shall be issued for no consideration.

2. The exercise price of each Option is $0.07 ( Exercise Price ).

3. Each Option entitles the holder to subscribe for one Share in Mindax Limited ACN 106 866 442 ( Company ) upon the payment of the Exercise Price per Share subscribed for.

4. The Options will lapse at 5:00 pm, Western Standard Time on 30 November 2025 ( Expiry Date ).

5. The Options are not transferable.

6. There are no participating rights or entitlements inherent in these Options and holders of the Options will not be entitled to participate in new issues of capital that may be offered to shareholders during the currency of the Option.

7. Option holders have the right to exercise their Options prior to the date of determining entitlements to any capital issues to the then existing shareholders of the Company made during the currency of the Options and will be granted a period of at least 10 business days before closing date to exercise the Options.

8. In the event the Company proceeds with a pro rata issue (except a bonus issue) of securities to the holders of Shares after the date of issue of the Options, the exercise price of the Options will be adjusted in accordance with the formula set out in ASX Listing Rule 6.22.2.

9. In the event of any re-organisation (including reconstruction, consolidation, subdivision, reduction or return of capital) of the issued capital of the Company, the Options will be re-organised as required by the Listing Rules, but in all other respects the terms of exercise will remain unchanged.

10. The Options shall be exercisable at any time until the Expiry Date ( Exercise Period ) by the delivery to the registered office of the Company of a notice in writing ( Notice ) stating the intention of the Option holder to exercise all or a specified number of Options held by them accompanied by an Option certificate and cleared funds for the subscription monies for the Shares. The Notice and cleared funds must be received by the Company during the Exercise Period. An exercise of only some Options shall not affect the rights of the Option holder to the balance of the Options held by it.

11. The Company shall allot the resultant Shares and deliver a statement of shareholdings with a holders’ identification number within 5 business days of exercise of the Options.

12. The Shares allotted shall rank, from the date of allotment, equally with the existing ordinary shares of the Company in all respects.

13. The Options are issued in accordance with a deferred taxation scheme as defined by the Australian Taxation Office.

14. The Options are granted under an arrangement to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies.

17

If you are attending the Meeting in person, please bring this with you for Securityholder registration.

MINDAX LIMITED | ABN 28 106 866 442

==> picture [68 x 58] intentionally omitted <==

Proxy Voting Form

Your proxy voting instruction must be received by 2.00pm (AWST) on Tuesday, 01 July 2025 , being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.

SUBMIT YOUR PROXY

Your proxy voting instruction must be received by2.00pm (AWST) on Tuesday, 01 July 2025, beingnot later than 48 hoursbefore the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.	Your proxy voting instruction must be received by2.00pm (AWST) on Tuesday, 01 July 2025, beingnot later than 48 hoursbefore the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.
SUBMIT YOUR PROXY
Complete the form overleaf in accordance with the instructions set out below. YOUR NAME AND ADDRESS The name and address shown above is as it appears on the Company’s share register. If this information is incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor portal:https://investor.automic.com.au/#/homeShareholders sponsored by a broker should advise their broker of any changes. STEP 1 – APPOINT A PROXY If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you leave this box blank, the Chair of the Meeting will be appointed as your proxy by default. DEFAULT TO THE CHAIR OF THE MEETING Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting, who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the Meeting will be voted according to the instructions set out in this Proxy Voting Form, including where the Resolutions are connected directly or indirectly with the remuneration of Key Management Personnel. STEP 2 - VOTES ON ITEMS OF BUSINESS You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid. APPOINTMENT OF SECOND PROXY You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms together. If you require an additional Proxy Voting Form, contact Automic Registry Services. SIGNING INSTRUCTIONS Individual: Where the holding is in one name, the Shareholder must sign. Joint holding: Where the holding is in more than one name, all Shareholders should sign. Power of attorney: If you have not already lodged the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Voting Form when you return it. Companies: To be signed in accordance with your Constitution. Please sign in the appropriate box which indicates the office held by you. Email Address: Please provide your email address in the space provided. By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual Report via email. CORPORATE REPRESENTATIVES If a representative of the corporation is to attend the Meeting the appropriate ‘Appointment of Corporate Representative’ should be produced prior to admission. A form may be obtained from the Company’s share registry online at https://automicgroup.com.au.
	BY MAIL: Automic GPO Box 5193 Sydney NSW 2001 PERSON: Automic Sydney NSW 2000 BY EMAIL: meetings@automicgroup.com.au BY FACSIMILE: WEBSITE: PHONE: Online Use your computer or smartphone to appoint a proxy at scan the QR code below using your smartphone Login & Click on ‘Meetings’. Use the this Proxy Voting Form.

==> picture [539 x 21] intentionally omitted <==

==> picture [37 x 171] intentionally omitted <==

Thursday, 03 July 2025 at Level 13, 26 St Georges Terrace, Perth WA 6000 hereby:

sees fit and at any adjournment thereof.

Unless indicated otherwise by ticking the “for”, “against” or “abstain” box you will be authorising the Chair to vote in accordance with the Chair’s voting intention.

STEP 2 - Your voting direction

Resolutions	For	Against Abstain	Against Abstain	Against Abstain
1 RATIFICATION OF PRIOR ISSUE OF SHARES
2 RATIFICATION OF PRIOR ISSUE OF SHARES
3 RATIFICATION OF PRIOR ISSUE OF SHARES
4 RATIFICATION OF PRIOR ISSUE OF SHARES
5 APPROVAL OF GRANT OF OPTIONS TO MR BENJAMI CHOW
6 APPROVAL OF GRANT OF OPTIONS TO MR QINGLONG ZENG
7 APPROVAL OF GRANT OF OPTIONS TO MR BIAOZHUN ZHU
Please note:If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution on a show of hands or on apoll andyour votes will not be counted in computing the required majority on apoll.

==> picture [539 x 21] intentionally omitted <==

==> picture [539 x 160] intentionally omitted <==

----- Start of picture text -----

2 3
Name:
/ /
----- End of picture text -----